发明名称 Use of brain natriuretic peptides (bnp), phosphorylated urodilatine, phosphorylated cdd/anp and combinations thereof
摘要 A pharmaceutical compsn. contg. Brain natriuretic peptide (BNP) as the active ingredient and opt. conventional pharmaceutical diluents, carriers, fillers or auxiliaries can be used in the treatment of lung and/or bronchial diseases. USE/ADVANTAGE - BNP can be used to treat lung and/or bronchial diseases, esp. obstructive respiratory disorders, such as bronchial and cardial asthma. Suitable doses are 5 ng.-1000 micro-g/kg. esp. 10 ng-100 micro-g/kg. taken parenterally esp. by intravenous injection or by inhalation. BNP is more effective than atrial natriuretic peptide (ANP) and urodilatin when used at the same doses.
申请公布号 AU6646594(A) 申请公布日期 1995.11.16
申请号 AU19940066465 申请日期 1994.04.20
申请人 HAEMOPEP PHARMA GMBH 发明人 WOLF-GEORG FORSSMANN;KLAUS-WOLF VON EICKSTEDT
分类号 A61K38/22 主分类号 A61K38/22
代理机构 代理人
主权项
地址